Home › Funds › Humankind Investments LLC › APGE

Humankind Investments LLC position in APGE

APOGEE THERAPEUTICS INC

Humankind Investments LLC reported holding 17,500 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.3M, representing 1.11% of its reported portfolio and ranking #17 among its reported holdings. Humankind Investments LLC has disclosed APGE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)17.50K sh
Reported value held$2.32M
Portfolio Weight1.11%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Humankind Investments LLC's APGE position evolved

Humankind Investments LLC first disclosed a stake in APGE in Q1 2026 at 17,500 shares (US$1.5M). The position peaked in Q2 2026 at 17,500 shares, worth US$2.3M. Across 2 filings, Humankind Investments LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 17,500 shares valued at US$2.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 17.50K $1.47M New
Q2 2026 17.50K $2.32M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →

FAQ

How long has Humankind Investments LLC held APGE?

Humankind Investments LLC has disclosed APGE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Humankind Investments LLC's current position in APGE?

As of Q2 2026, Humankind Investments LLC holds 17.50K shares of APGE (APOGEE THERAPEUTICS INC), valued at $2.32M, representing 1.11% of its reported portfolio and ranking #17.

Has Humankind Investments LLC been buying or selling APGE?

In the latest 13F filing (Q2 2026), Humankind Investments LLC held unchanged its position in APGE. The position peaked in Q2 2026 at 17.50K shares.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.